The Symposium is open to healthcare practitioners and researchers and will include various speakers covering a variety of topics-ranging from emerging evidence to current clinical practices on the practical application of cannabinoid-based medicine.
The speakers include Canadian and international key opinion leaders, clinicians, and scientists from leading academic, research, and clinical organizations.
CHECK OUT OUR FEATURED SPEAKERS FOR THIS YEAR’S EVENT
This event is invite only
Register Now
Call for Abstracts: Avicanna’s 5th Medical Symposium on Cannabinoid-Based Medicine
June 6th, 2025 | Toronto, Canada
We invite abstract submissions for poster presentations that highlight original research, clinical experiences, and forward-thinking innovations across the cannabinoid medicine spectrum.
Submission Guidelines
- Abstract Length: 250–300 words (excluding title/authors)
- Format:
- Abstracts must be structured into five sections: Title, Rationale, Methods, Results, and Conclusions
- The maximum word count is 300 words, excluding title, authors, affiliations, and funding sources
- Include funding sources, abbreviations, and references (Note: These will not count towards the final word count)
- Institutional information must be provided for all authors
- Figures, tables, and other illustrations are not permitted in the submission
- Data previously presented at other meetings is eligible for consideration
- Posters must be submitted by one of the study authors or investigators; third-party submissions will not be accepted
- Deadline: May 16, 2025 (11:59 PM EST)
- Eligibility: Open to researchers, clinicians, policymakers, and industry experts
- Review Process: Peer-reviewed for scientific merit, innovation, and relevance
- Notification of Acceptance: May 23, 2025, by 5:00 PM EST
Submit your abstract via our online form
THANK YOU TO EVERYONE WHO JOINED US AT LAST YEAR’S EVENT
We had the pleasure of hosting our 4th annual medical symposium, where attendees had the opportunity to join medical professionals and industry leaders presenting the latest advancements in medical cannabis.
The videos below showcase all the compelling presentations and panel discussions on the various of topics that were presented throughout the four sessions.
1. Real World Evidence Studies
2. Access to Medical Cannabis
3. Clinical Application
4. Concluding Session
Opening Remarks
Aras Azadian
Avicanna
Session 1: Real-World Evidence Studies
Dr. Camila Sofia Arriagada Egnen
Hospital for Sick Children
Evaluating a Cannabidiol Cream in Children with Epidermolysis Bullosa
Dr. Karolina Urban
Avicanna
Dr. Hance Clarke (University Health Network), Erin Prosk (Sante Cannabis)
Session 2: Access to Medical Cannabis
Samantha Aitken
MyMedi.ca
Dr. Carlo De Angelis
Sunnybrook Health Sciences Centre
Dr. Carlo De Angelis (Sunnybrook Health Sciences Centre)
Blake Pearson (Pearson Health)
Cristina Montoya (Arthritis Society Patient Advocate)
Session 3: Clinical Application
Dr. Alan Bell
University of Toronto
Dr. Hance Clarke
University Health Network
Dr. Evan Lewis
Neurology Centre of Toronto
Use of Cannabinoids in Pediatric Refractory Epilepsy Patients
Dr.Alan Bell (University of Toronto)
Dr. Hance Clarke (University Health Network)
Dr. Evan Lewis (Neurology Centre of Toronto)
The Challenges with Establishing Medical Cannabis Treatment Plans for Patients
Session 4: Concluding Session
Dr. Tania Di Renna
Women’s Health College, Toronto Academic Pain Medicine Institute
The Potential Role of Cannabinoid-based Medicines in Women’s Health
Aras Azadian (Avicanna)
Keith Strachan (Medipharm Labs)
Andrew Bevan (Canopy Growth)
Dr. Julia Hoeng (Vectura Fertin Pharma)